Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Excelsior Medical Co's Enterprise Value is NT$13,149 Mil.
Excelsior Medical Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was NT$1,213 Mil. Therefore, Excelsior Medical Co's EV-to-EBIT ratio for today is 10.84.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Excelsior Medical Co's Enterprise Value is NT$13,149 Mil.
Excelsior Medical Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was NT$1,524 Mil. Therefore, Excelsior Medical Co's EV-to-EBITDA ratio for today is 8.63.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Excelsior Medical Co's Enterprise Value is NT$13,149 Mil.
Excelsior Medical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was NT$8,983 Mil. Therefore, Excelsior Medical Co's EV-to-Revenue ratio for today is 1.46.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Excelsior Medical Co (TPE:4104) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Excelsior Medical Co's current Enterprise Value is NT$13,149 Mil.
Excelsior Medical Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1,213 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Excelsior Medical Co's current Enterprise Value is NT$13,149 Mil.
Excelsior Medical Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1,524 Mil.
Excelsior Medical Co's current Enterprise Value is NT$13,149 Mil.
Excelsior Medical Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$8,983 Mil.
Excelsior Medical Co's current Enterprise Value is NT$13,149 Mil.
Excelsior Medical Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$311 Mil.
Excelsior Medical Co's current Enterprise Value is NT$13,149 Mil.
Excelsior Medical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$225 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Excelsior Medical Co Enterprise Value Related Terms
Excelsior Medical Co Enterprise Value Historical Data
* Premium members only.
The historical data trend for Excelsior Medical Co's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:4104 vs MCK, COR, CAH: Enterprise Value Comparison
For the Medical Distribution subindustry, Excelsior Medical Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Excelsior Medical Co Enterprise Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Excelsior Medical Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Excelsior Medical Co's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Excelsior Medical Co's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of NT$13,149 Mil mean?
Excelsior Medical Co (TPE:4104) has a Enterprise Value of NT$13,149 Mil as of Aug. 03, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Excelsior Medical Co and its competitors.
Is Excelsior Medical Co's Enterprise Value too high?
Excelsior Medical Co's current Enterprise Value is NT$13,149 Mil. Overall, Excelsior Medical Co has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Excelsior Medical Co's Enterprise Value compare to MCK and COR?
Excelsior Medical Co's Enterprise Value of NT$13,149 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Distribution company?
A good Enterprise Value depends on the Medical Distribution industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Excelsior Medical Co and its competitors. Excelsior Medical Co's current Enterprise Value is NT$13,149 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Excelsior Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Excelsior Medical Co (TPE:4104) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$87.68, compared to a current price of NT$70.00 — trading 20.2% below its estimated fair value. The current Enterprise Value is NT$13,149 Mil. Excelsior Medical Co's overall GF Score™ is 87/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Excelsior Medical Co (TPE:4104), the current Enterprise Value is NT$13,149 Mil as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Excelsior Medical Co (TPE:4104) Overvalued in 2026?
Based on GuruFocus' analysis, Excelsior Medical Co stock appears to be undervalued.
The current stock price of NT$70.00 is trading 20.2% below its estimated GF Value™ of NT$87.68.
GuruFocus considers Excelsior Medical Co to be Modestly Undervalued.
Key valuation signals for TPE:4104:
Enterprise Value: NT$13,149 Mil
GF Value™: NT$87.68 vs. price of NT$70.00 (20.2% below fair value)
No single metric tells the full story. See the TPE:4104 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Excelsior Medical Co Ltd is engaged in the sale of medical supplies and medicines, home medical devices, and medical equipment with brand names of local and foreign manufacturers. Its product offerings include Fasflo hollow fiber dialyzer, Renabio sodium chloride injection, acid concentrates, Sunder blood purification tubing set, JMS blood bags, etc. The Group's reportable segments include Excelsior, Dynamic, Arich, and Others. Maximum revenue is generated from the Excelsior segment. Geographically, it derives key revenue from Taiwan and also has a presence in Hong Kong, China, the Philippines, Malaysia, and Indonesia.
87GF Score
Get the complete analysis for TPE:4104
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4104 has been successfully added to your 
